The view from K2: Stephen Scott shares three companies he favours
Side-effects caused by the AstraZeneca COVID-19 vaccine have created a detour on Australia’s road to recovery, but K2
Side-effects caused by the AstraZeneca COVID-19 vaccine have created a detour on Australia’s road to recovery, but K2
As the world emerges from the depths of the pandemic Australia appears to have once again lived up
This week we were joined by Stephen Scott, Senior Portfolio Manager at K2 Asset Management who shares his
When it comes to picking small cap companies to invest in, K2 Asset Management’s Stephen Scott turns to
This week we were joined by Shaun Cartwright, Managing Director at Viriathus Australia who shares his unique insights
The price of lithium hit a two-year high earlier this month as demand for the rare earth element
Present day markets are pricing shares on the momentum of their industries, rather than the stock’s underlying value,
This week we were joined by Dean Fergie, Director & Portfolio Manager at Cyan Investment Management who discusses
Markets are willing to believe companies are worth far more than their fundamentals would suggest, and this behaviour
Historically high unemployment rates created by the “great virus crisis” of 2020 are tipped to be a boom